Stephen F. Mahoney's Net Worth

$2.48 Million

Estimate Recalculated Nov 1, 2024 04:44AM EST

Who is Stephen F. Mahoney?

Stephen F. Mahoney has an estimated net worth of $2.48 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., Magenta Therapeutics, Inc., and Viridian Therapeutics, Inc.\DE.

SEC CIK

Stephen F. Mahoney's CIK is 0001741389

Past Insider Trading and Trends

2018 was Stephen F. Mahoney's most active year for acquiring shares with 4 total transactions. Stephen F. Mahoney's most active month to acquire stocks was the month of April. 2018 was Stephen F. Mahoney's most active year for disposing of shares, totalling 2 transactions. Stephen F. Mahoney's most active month to dispose stocks was the month of April. 2018 saw Stephen F. Mahoney paying a total of $99,995.17 for 169,834 shares, this is the most they've acquired in one year. In 2021 Stephen F. Mahoney cashed out on 5,736 shares for a total of $38,603.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93

President & COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 17
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
—
—
0
Sep 20
Form 4
+8.73%
6.39K
—
—
79.59K
Feb 9 - May 29
Form 3
—
0
—
—
0
No matching records found

Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.03%
3K
$0.94
$2,820.00
17.26K
Nov 30
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Feb 15
Form 4
-28.68%
-5.74K
$6.73
-$38,603.28
14.26K
Sep 16
Form 4
∞
20K
—
—
20K
Sep 14
Form 4
—
0
—
—
0
Nov 2
Form 3
—
0
—
—
0
No matching records found

Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 30
Form 3
—
0
—
—
0
No matching records found